Cargando…
The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. In China, most HCC patients are diagnosed with advanced disease and in these cases surgery is challenging. Conversion therapy can be used to change unresectable HCC into resectable disease and is a pote...
Autores principales: | Bai, Jinfeng, Huang, Ming, Song, Bohan, Luo, Wei, Ding, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983081/ https://www.ncbi.nlm.nih.gov/pubmed/36855803 http://dx.doi.org/10.1177/15330338231159718 |
Ejemplares similares
-
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021) -
Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects
por: Zhang, Zhongqi, et al.
Publicado: (2023) -
Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
por: Lu, Ren-Cai, et al.
Publicado: (2019) -
Conversion of Chitin to Defined Chitosan Oligomers: Current Status and Future Prospects
por: Schmitz, Christian, et al.
Publicado: (2019) -
Management of Hepatocellular Carcinoma: Current Status and Future Directions
por: Au, Jennifer S., et al.
Publicado: (2015)